| Cardiovascular Risk Management |
1 |
1 |
| Lipids Management |
0 |
0.9 |
| Cardiac Surgery |
0 |
0.57 |
| LDL Cholesterol |
0 |
0.53 |
| Coronary Artery Disease (CAD) |
0 |
0.45 |
| Genetics |
0 |
0.42 |
| Genomic Medicine |
0 |
0.42 |
| Genetic Testing |
0 |
0.37 |
| Revenue and Practice Management |
0 |
0.33 |
| Cardiovascular disease |
0 |
0.32 |
| Salary and Compensation |
0 |
0.32 |
| Familial Hypercholesterolemia |
0 |
0.99 |
| Hypercholesterolemia |
0 |
0.98 |
| Statins |
0 |
0.21 |
| Atherosclerosis |
0 |
0.18 |
| Angina Pectoris |
0 |
0.15 |
| Aortic Stenosis |
0 |
0.15 |
| Congenital Heart Disease |
0 |
0.15 |
| Aortic Valve |
0 |
0.1 |
| Artery |
0 |
0.1 |
| Child |
0 |
0.1 |
| Epidemiology |
0 |
0.1 |
| Europe |
0 |
0.1 |
| Hand |
0 |
0.1 |
| Hospital |
0 |
0.1 |
| Infarction |
0 |
0.1 |
| Metabolism |
0 |
0.1 |
| PCSK9 |
0 |
0.1 |
| Percutaneous Coronary Intervention |
0 |
0.1 |
| Smoking |
0 |
0.1 |
| Spain |
0 |
0.1 |
| Stenosis |
0 |
0.1 |
| Valve Replacement |
0 |
0.1 |
| Xanthoma |
0 |
0.1 |
| Myocardial Infarction (MI) |
0 |
0.09 |
| Tobacco Cessation |
0 |
0.09 |